Navigation Links
Alseres Pharmaceuticals, Inc. Reports Third Quarter 2008 Operational and Financial Results
Date:11/13/2008

- The cash and cash equivalents available at September 30, 2008 and our ability to control certain costs, including those related to clinical trial programs, preclinical activities, and certain general and administrative expenses has enabled us to meet our anticipated cash expenditures into November 2008. We must immediately raise additional funds in November 2008 in order to continue operations.

Alseres Pharmaceuticals Upcoming Milestones

-- Enrollment in the first part of the POET-2 Phase III clinical trial for our Altropane molecular imaging agent is expected to be complete in early 2009. We are currently identifying appropriate sites and investigators for the Phase III, POET-2 registration trials which are planned to be initiated in mid-2009.

-- Twelve month interim data for the Phase I/IIa clinical trial of Cethrin will be presented at the Society for Neuroscience Meeting, November 15-19, 2008, in Washington, DC by Dr. Michael Fehlings, principal Investigator of the Cethrin Phase I/IIa trial.

-- We are pursuing development and commercialization partnerships for our molecular imaging and regenerative therapy assets. We expect to continue confidential discussions with franchise leaders interested in our molecular imaging and regenerative therapeutic pipelines. We expect to advance discussions toward partnerships and scientific collaborations over the remainder of the year.

Conference Call Access Information

The company will host a conference call to discuss results on November 14, 2008, at 9:00 a.m. Eastern Time. To access the conference call, please dial 877-718-5095 for domestic and 719-325-4818 for international calls. The code for this conference call is 3501954. Please dial in 5 to 10 minutes prior to the scheduled start time. A replay of the call will be posted on the Investor Relations section of our website, http://www.alseres.com, within 48 hours following the co
'/>"/>

SOURCE Alseres Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Alseres Pharmaceuticals, Inc. Raises $5 Million
2. Alseres Pharmaceuticals, Inc. Reports 2007 Financial Results and Provides Company Highlights
3. Alseres Pharmaceuticals to Host 2007 Financial Results Conference Call
4. Alseres Pharmaceuticals Presents Inosine and Dopamine Transporter (DAT) Blocker Preclinical Data at the American Society for Experimental NeuroTherapeutics (ASENT) Conference
5. Alseres Pharmaceuticals, Inc. to Present at Windhovers Therapeutic Area Partnerships Conference
6. Alseres Pharmaceuticals, Inc. to Present at Bio Investor Forum 2007 Annual Meeting
7. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
8. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
9. Transcept Pharmaceuticals, Inc. to Present at the Natixis Bleichroeder Second Annual Hidden Gems Conference
10. Pacira Pharmaceuticals, Inc. Adds Experienced Physician Dr. David St. Peter to Leadership Team
11. Rib-X Pharmaceuticals, Inc. Announces Formation of Clinical Advisory Board
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/19/2013)... , June 19, 2013 ... Book Bureau presents Innovative Drug ... Formulation Technology Licensing Opportunities for ... ) There are ... controlled release drugs approved all ...
(Date:6/19/2013)... 2013 Express Diagnostics Int’l, Inc., manufacturer ... that it has received Class III medical device license ... DrugCheck® NxStep Onsite Drug Screen Cup in ... screening device in near-patient settings, such as physicians’ offices. ... Health Canada Class III approval for 24 different drugs ...
(Date:6/18/2013)... 18, 2013 In support of Swiss ... Consulate General of Switzerland in New York is pleased ... MS Tûranor PlanetSolar , to Manhattan. PlanetSolar is ... Expedition 2013 tour with scientists on board from the ... d’Aboville, runs exclusively on energy from the sun and ...
(Date:6/18/2013)... 18, 2013 DuPont welcomes 48 of ... annual DuPont National AgriScience Teachers Ambassador Academy this week ... Chestertown, Md. , The NATAA “Ag Academy” ... is a special project of the National FFA ... Educators (NAAE) . The highly recommended agriscience teachers, ...
Breaking Biology Technology:Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 2Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies 3Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 2Express Diagnostics’ DrugCheck® On-site Test Cup Receives Health Canada Class III Medical Device Approval 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 2Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 3Switzerland’s MS Tûranor PlanetSolar, the World’s Largest Solar Boat, Arrives in New York City 4DuPont Sponsors National AgriScience Ambassador Academy 2DuPont Sponsors National AgriScience Ambassador Academy 3
... Sigma-Aldrich Corporation,(Nasdaq: SIAL ) will be presenting at ... 25th at 1:00 PM ET in New York. ... the,Internet available at http://ir.sigmaaldrich.com . Users can click ... on, http://ir.sigmaaldrich.com users will need to have Media ...
... ROCKVILLE, Md., Sept. 14 Human Genome,Sciences, Inc. (Nasdaq: ... the,Merrill Lynch Global Pharmaceutical, Biotech & Medtech Conference in ... http://www.hgsi.com (Logo: http://www.newscom.com/cgi-bin/prnh/20010612/HGSLOGO ) ... will present,an overview of the company on Tuesday, September ...
... Sept. 14 Palatin,Technologies, Inc. (Amex: PTN ) announced ... 30, 2007. Palatin reported a net loss of,$6.1 million, or ... 30, 2007, compared to a net loss of $7.9 million, ... in 2006. Total revenues in the,quarter ended June 30, 2007 ...
Cached Biology Technology:Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 2Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 3Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 4Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 5Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 6Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 7Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2007 Results; Teleconference and Webcast to be held on September 18, 2007 8
(Date:6/19/2013)... MOUNTAIN VIEW, Calif. , June 20, 2013 ... the personalized cosmeceuticals market, Frost & Sullivan recognizes ... Sullivan Award for New Product Innovation. geneOnyx leverages ... point-of-care testing to create an on-the-spot genetic test ... only a single-step DNA collection procedure from saliva ...
(Date:6/19/2013)... The protected area network in Tanzania is playing a ... as they move west in response to climate and ... University of York., Using data on savannah birds from ... Tanzanian bird distributions over recent decades - the researchers ... stones as they move to areas further west where ...
(Date:6/19/2013)... , June 19, 2013   ... clinical laboratory diagnostics technology for conducting on-demand, ... diabetes testing, as well as analysis of ... and platelet counts. The new system enables ... lab results for physicians and their patients, ...
Breaking Biology News(10 mins):Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 2Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 3Frost & Sullivan Applauds geneOnyx for its DNA Testing Solution for the Personalized Cosmeceuticals Market 4Protected areas provide African birds with stepping stones to survival 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 2Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 3Mercy Lab Offers Faster On-demand Diabetes Testing, Cellular Studies 4
... target muscle may reverse the symptoms of a rare ... mice conducted by medical geneticists at Duke University Medical ... Pompe disease usually die before they reach the age ... targeting corrective genes to muscles may have application in ...
... the flow of water molecules through the brain can help ... if a patient's tumor will shrink, a new study shows. ... developed the assessment, which they call a functional diffusion map. ... diffusion, or movement, of water through the brain and mapped ...
... historic anthropology expedition to Ethiopia's Lake Turkana basin, researchers ... time are roughly 195,000 years old. The researchers ... we all trace to an ancient line that first ... recently as 50,000 years ago. , Ian McDougall of ...
Cached Biology News:Muscle-targeted gene therapy reverses rare muscular dystrophy in mice 2Muscle-targeted gene therapy reverses rare muscular dystrophy in mice 3New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 2New imaging method gives early indication if brain cancer therapy is effective, U-M study shows 3New Clues Add 40,000 Years to Age of Human Species 2New Clues Add 40,000 Years to Age of Human Species 3New Clues Add 40,000 Years to Age of Human Species 4
... particle based purification systems provide high speed ... sample. They offer increased throughput and reproducible ... KingFisher, KingFisher mL and KingFisher 96, covering ... Each system consists of an instrument, specially ...
... PROTECT FROM MOISTURE. AVOID FREEZE/THAW CYCLES. ... cells in vitro by DNA ... their anti-histone-facilitated detection. In this assay, mono- ... binding proteins. Anti-Histone 3 (H3) biotin-labeled antibody ...
... optimized cell lines in combination with ... nucleofection parameters. Nucleofector Kits are only ... Device., Different cell lines can be ... efficiencies and viabilities are given in ...
... solution or in a gel piece, we can ... be digested to produce a mixture of peptides. ... determined by MALDI-TOF, and the amino acid sequences ... will be determined by MALDI-TOF/TOF. The masses and ...
Biology Products: